grant

A Vaccine for Lymphatic Filariasis, LFGuard™

Organization PAI LIFE SCIENCES, INC.Location SEATTLE, UNITED STATESPosted 1 Mar 2019Deadline 30 Nov 2027
NIHUS FederalResearch GrantFY202621+ years oldAdjuvantAdultAdult HumanAffectAgonistAlum AdjuvantAnimal ModelAnimal Models and Related StudiesAnimal TestingAntigensAssayBacteriaBancroftian ElephantiasisBioassayBiologic SciencesBiologicalBiological AssayBiological SciencesBioscienceBookletsBrochuresBrugia malayiChemistryChronicClinicalClinical ResearchClinical StudyClinical TrialsContracting OpportunitiesContractsCountryCoupledCulicidaeCyclic GMPDALYDevelopmentDiseaseDisorderDomestic RabbitDrug TherapyDrugsEffectivenessEndemic DiseasesEngineeringExperimental Animal ModelFilaria bancroftiFilaria sanguinis hominisFilarial ElephantiasesFormulationFutureGerbilsGrantGroups at riskGuanosine Cyclic MonophosphateHelminthsHomolog of Drosophila TOLLHumanIND FilingIND applicationIND packageIND submissionImmunityIncidenceIndividualInfectionInfection ControlInfectious AgentInterruptionInvestigational New Drug ApplicationInvestigatorsJirdLarvaLicensingLife SciencesLymph SystemLymphaticLymphatic FilariasisLymphatic NetworkLymphatic SystemLymphatic System Reticuloendothelial SystemLymphedemaM mulattaM. mulattaMacaca mulattaMacaca rhesusMedicationMerioneMiceMice MammalsModelingModern ManMorbidityMosquitoesMurineMusNational Institutes of HealthOryctolagus cuniculusPamphletsParasitesParasitic WormsPathologyPatientsPeople at riskPersonsPersons at riskPharmaceutical PreparationsPharmacological TreatmentPharmacotherapyPhasePopulations at RiskPredispositionPreventative ImmunizationPreventative vaccinationPreventative vaccinePreventive ImmunizationPreventive vaccinationPreventive vaccineProphylactic immunizationProphylactic treatmentProphylactic vaccinationProphylactic vaccineProphylaxisProteinsProtocolProtocols documentationProtozoaProtozoalPublic HealthRabbitsRabbits MammalsRecombinant Fusion ProteinsReportingResearchResearch PersonnelResearch ResourcesResearchersResolutionResourcesRhesus MacaqueRhesus MonkeyRiskRodentRodent ModelRodentiaRodents MammalsRunningSBIRSafetySmall Business Innovation ResearchSmall Business Innovation Research GrantSterilitySusceptibilityTLR4TLR4 geneTechnologyTestingTherapeuticToll HomologueToxicologyTransmissionUnited States National Institutes of HealthVaccinesVirusWorld HealthWorld Health OrganizationWritingWuchereria bancroftiadulthoodalumaluminum sulfatebiologiccGMPcell bankchemotherapyclinical developmentcommunicable disease transmissiondesigndesigningdevelopmentaldisability-adjusted life yearsdisease classificationdisease transmissiondisorder classificationdrug detectiondrug interventiondrug testingdrug treatmentdrug/agentfirst in manfirst-in-humanfunctional mimicsglobal healthimmune response to vaccinationimmune response to vaccinesimmunogeninfectious disease transmissioninfectious organismlymph edemalymphatic edemamanufacturemodel of animalmortalityneglected tropical diseasesnon-compliancenon-compliantnon-human primatenoncompliancenoncompliantnonhuman primatenosologynovelpharmaceutical interventionpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticsphase 2 studyphase II studyphysical disabilityphysically disabledphysically handicappedpre-clinicalpreclinicalpreventpreventingprogramsprophylacticresolutionssteriletoll-like receptor 4transmission processvaccine associated immune responsevaccine candidatevaccine efficacyvaccine immune responsevaccine immunogenicityvaccine induced immune response
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
Lymphatic filariasis (LF) is one of only a small number of diseases classified as potentially

eradicable. In 1997, the World Health Assembly passed a resolution to eliminate LF as a public

health problem and the approach involved yearly concurrent mass drug administration (MDA)

to the at-risk population in 52 countries. According…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
A Vaccine for Lymphatic Filariasis, LFGuard™ — PAI LIFE SCIENCES, INC. | UNITED STATES | Mar 2019 | Dev Procure